← CVS HEALTH Corp

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $177.5b
$184.8b +4.08%
$193.9b +4.95%
$256.8b +32.41%
$268.7b +4.65%
$292.1b +8.71%
$322.5b +10.39%
$357.8b +10.95%
$372.8b +4.20%
$402.1b +7.85%
$415.1b +3.24%
Cost of Revenue $148.7b
$156.2b +5.08%
$156.4b +0.15%
$158.7b +1.45%
$164.0b +3.32%
$175.8b +7.21%
$196.9b +12.00%
$217.1b +10.26%
$206.3b -4.98%
$221.2b +7.21%
$356.3b +61.12%
Cost of products sold $146.5b
$153.4b +4.72%
$156.4b +1.95%
$158.7b +1.45%
$164.0b +3.32%
$175.8b +7.21%
$196.9b +12.00%
$217.1b +10.26%
$206.3b -4.98%
$221.2b +7.21%
—
Gross Profit (derived) $28.9b
$28.5b -1.08%
$37.5b +31.27%
$98.1b +161.68%
$104.7b +6.80%
$116.3b +11.06%
$125.6b +7.97%
$140.7b +12.03%
$166.5b +18.37%
$180.9b +8.63%
$58.7b -67.53%
Interest Income (Expense), Net ($1.1b)
($1.0b) +1.61%
— $0 $0 — — — — — —
Amortization of Intangible Assets $795.0m $817.0m $1.0b $2.4b $2.3b $2.3b $1.8b $1.9b $2.0b $2.0b —
Restructuring charges ($1.0m) ($8.0m) $0 $0 ($9.0m) $0 $0 $507.0m $1.2b $0 —
Operating Expenses $18.5b $19.0b $21.4b $33.5b $35.1b $37.1b $38.2b $39.8b $41.6b $45.0b $44.7b
Total operating costs $167.2b $175.2b $190.6b $244.8b $254.8b $278.9b $314.7b $344.0b $364.3b $397.4b —
Operating Income (Loss) $10.3b
$9.5b -7.94%
$4.0b -57.75%
$12.0b +198.11%
$13.9b +16.05%
$13.2b -5.16%
$7.7b -41.29%
$13.7b +77.42%
$8.5b -38.03%
$4.7b -45.28%
$14.0b +200.71%
Interest Expense $1.1b $1.1b $2.6b $3.0b $2.9b $2.5b $2.3b $2.7b $3.0b ($3.1b) $3.1b
Investment Income, Interest $20.0m $21.0m — — — — — — — — —
Investment Income, Net $20.0m $21.0m $660.0m $1.0b $798.0m $1.2b $838.0m $1.2b $2.2b $2.2b —
Net Investment Income $20.0m $21.0m $660.0m $1.0b $798.0m $1.2b $838.0m $1.2b $2.2b $2.2b —
Gain (Loss) Related to Litigation Settlement — — — — — — ($5.8b) $0 ($100.0m) — —
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement — ($187.0m) $0 $0 — — — — — — —
Other Nonoperating Income (Expense) — — $4.0m $124.0m $206.0m $182.0m $169.0m $88.0m $99.0m $112.0m —
Other income $28.0m $208.0m ($4.0m) ($124.0m) ($206.0m) ($182.0m) ($169.0m) ($88.0m) ($99.0m) $112.0m —
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — — — — — — — $1.3b $5.8b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8.6b $8.3b $1.4b $9.0b $9.8b $10.4b $5.6b $11.2b $6.1b $2.1b $5.8b
Income tax provision $3.3b $1.6b $2.0b $2.4b $2.6b $2.5b $1.5b $2.8b $1.6b $408.0m —
Current Income Tax Expense (Benefit) $3.3b $3.1b $2.0b $3.0b $3.1b $3.0b $3.5b $3.5b $2.1b $306.0m $902.0m
Net Income (Loss) Attributable to Parent $5.3b
$6.6b +24.54%
($594.0m) -108.97%
$6.6b +1216.84%
$7.2b +8.22%
$7.9b +10.18%
$4.1b -47.55%
$8.3b +101.11%
$4.6b -44.70%
$1.8b -61.68%
$4.9b +176.58%
Net Income (Loss) Attributable to Noncontrolling Interest $2.0m $1.0m ($2.0m) ($3.0m) $13.0m ($12.0m) $16.0m $24.0m ($28.0m) ($40.0m) $4.9b
Income (Loss) from Continuing Operations, Per Basic Share $5 $6 ($1) $5 $5 $6 $3 — — — —
Income (Loss) from Continuing Operations, Per Diluted Share $5 $6 ($1) $5 $5 $6 $3 — — — —
Earnings Per Share, Basic $4.93 $6.47 ($0.57) $5.10 $5.48 $6.00 $3.16 $6.49 $3.67 $1.40 $3.82
Earnings Per Share, Diluted $4.90 $6.44 ($0.57) $5.08 $5.46 $5.95 $3.14 $6.47 $3.66 $1.39 $3.79
Common Stock, Dividends, Per Share, Declared $1.70 $2.00 $2.00 $2.00 $2.00 $2.00 $2.20 $2.42 $2.66 $2.66 —
Basic (in shares) $1.1b $1.0b $1.0b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b
Diluted (in shares) $1.1b $1.0b $1.0b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b $1.3b
Weighted Average Number of Shares Outstanding, Basic 1.1b 1.0b 1.0b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b
Weighted Average Number of Shares Outstanding, Diluted 1.1b 1.0b 1.0b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b 1.3b
Additional Financial Items
Depreciation, Depletion and Amortization, Nonproduction $2.5b $2.5b — — — — — — — — —
Deferred Policy Acquisition Costs, Amortization Expense — — — — — — — $265.0m $299.0m $346.0m —
Goodwill, Impairment Loss $0 $181.0m $6.1b $0 $0 $431.0m $0 $0 $0 $5.7b $5.7b
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims — — — — — — — $86.0b $114.8b $125.3b —
Other Cost and Expense, Operating $18.5b $19.0b $21.4b $33.5b $35.1b $37.1b $38.2b $39.8b $41.6b $45.0b —
Realized Investment Gains (Losses) — — $3.0m $199.0m $52.0m $176.0m ($320.0m) ($497.0m) $117.0m ($44.0m) —
Premiums — $3.6b $8.2b $63.1b $69.4b $76.1b $85.3b $99.2b $122.9b $134.8b —
Health care costs $2.2b $2.8b $6.6b — — $64.2b $71.1b $86.2b $115.1b $125.5b —
Goodwill impairment $0 $181.0m $6.1b $0 $0 $431.0m $0 $0 $0 $5.7b $5.7b
Loss on assets held for sale — — — — $0 $0 $2.5b $349.0m $0 $0 —
Gain on early extinguishment of debt $643.0m $0 $0 $79.0m $1.4b $452.0m $0 $0 ($491.0m) $0 —
Gain on deconsolidation of subsidiary — — — — — — — $0 $0 $483.0m —
Net (income) loss attributable to noncontrolling interests ($2.0m) ($1.0m) $2.0m $3.0m ($13.0m) $12.0m ($16.0m) ($24.0m) $28.0m $40.0m $4.9b
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $5.3b $6.6b ($597.0m) $6.6b $7.2b $7.9b $4.1b — — — —
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $5.3b $6.6b ($596.0m) $6.6b $7.2b $7.9b $4.2b — — — —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($1.0m) ($8.0m) $0 $0 ($9.0m) $0 $0 $507.0m $1.2b $0 —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.